GlassScriptPhysician profile
Scott L Barry
NPI 1811939036
$8,006.62
in general payments reported to CMS, 2019-2025
6 companies · $37.37 in 2025
The $37.37 reported for 2025 was less than what a typical Endodontics provider received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $262 · 2021: $76.66 · 2022: $6,807 · 2023: $281 · 2024: $227 · 2025: $37.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $481 · Food and Beverage: $64.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $481.00 |
| Food and Beverage | $64.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonendo INC | $6,515.76 | 2019-2024 | Gentlewave G4 Console, Posterior Cleanflow Procedure Instrument With Matrices |
| A-Dec, INC. | $1,201.00 | 2019-2024 | |
| Dentsply Sirona INC | $143.83 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $78.66 | 2022 | |
| USA Angelalign Technology Corp | $37.37 | 2025 | |
| Nusmile, LTD. | $30.00 | 2023 | Zarc Files |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$37,109.86 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.